Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

K-V Pharma Settlement With Hologic Approved
Motley Fool
Sunday, December 30, 2012 - 12:11pm
tags:
KV Pharmaceutical, Hologic, lawsuits
Pfizer’s Backing Spurs Halozyme's Growth
Motley Fool
Sunday, December 30, 2012 - 12:09pm
tags:
Pfizer, Halozyme
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sunday, December 30, 2012 - 12:07pm
tags:
Medifast, Questcor Pharmaceuticals, Pluristem Therapeutics
Pharmaceutical firm caught in kickback scheme
Examiner
Saturday, December 29, 2012 - 10:46am
tags:
Victory Pharma, legal, kickbacks
Takeda and Amylin terminate obesity compound co-development agreement
equities.com
Saturday, December 29, 2012 - 10:38am
tags:
Takeda, Amylin, obesity, weight loss
Mylan Launches Generic Nordette 28 Tablets
PR NewsWire
Saturday, December 29, 2012 - 10:37am
tags:
Mylan, generics, Nordette
Watson challenges patent on cancer drug Velcade
PharmPro
Saturday, December 29, 2012 - 10:35am
tags:
Watson, Velcade, patents, generics
Mylan Launches Generic Mylantin Chewable Tablets
Melodika
Saturday, December 29, 2012 - 10:34am
tags:
Mylan, Mylantin, generics
Gabelli: Teva Pharmaceutical (NYSE:TEVA) set to rebound from the lowest valuations among peers
The Point Daily
Saturday, December 29, 2012 - 10:32am
tags:
Teva
Raptor To Rise On Proven Strategy & Upcoming FDA Decision
Seeking Alpha
Saturday, December 29, 2012 - 10:31am
tags:
Raptor, procysbi, nephropathic cystinosis
Is Johnson and Johnson Still a Safe Play?
Wall St Cheat Street
Saturday, December 29, 2012 - 10:28am
tags:
JNJ
Viagra vs. Cialis: Little Blue Pill Is Losing Big
Bloomberg
Saturday, December 29, 2012 - 10:02am
tags:
Viagra, Cialis, Pfizer, Eli Lilly, impotence
Why Aegerion Keeps Winning
Motley Fool
Saturday, December 29, 2012 - 9:59am
tags:
Aegerion
Eliquis Cannot Alter Patent and Demographic Losses for Pfizer
Motley Fool
Saturday, December 29, 2012 - 9:58am
tags:
Eliqius
Merck & Co Inc (MRK): Today's Featured Drugs Laggard
The Street
Saturday, December 29, 2012 - 9:55am
tags:
Merck
BGI-Shenzhen Extends Tender Offer for Complete Genomics, Inc.
Yahoo/PR NewsWire
Saturday, December 29, 2012 - 9:53am
tags:
BGI-Shenzhen, Complete Genomics
Some Numbers at Sequenom that Make Your Stock Look Good
Motley Fool
Saturday, December 29, 2012 - 9:52am
tags:
Sequenom
Amgen Inc (AMGN): Today's Featured Health Care Laggard
The Street
Saturday, December 29, 2012 - 9:50am
tags:
Amgen
Can This Company Cure an Investor’s Portfolio?
Motley Fool
Saturday, December 29, 2012 - 9:50am
tags:
Amgen
Pomerantz Law Firm Has Filed a Class Action Against Hemispherx Biopharma, Inc., and Certain Officers
Yahoo/Globe NewsWire
Saturday, December 29, 2012 - 9:47am
tags:
Hemispherx Biopharma, lawsuits

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.